What’s Ahead for CORD BLOOD AMERICA (OTCMKTS:CBAI) After More Shorted Shares?

January 14, 2018 - By Maria Brooks

The stock of CORD BLOOD AMERICA (OTCMKTS:CBAI) registered an increase of 352% in short interest. CBAI’s total short interest was 22,600 shares in January as published by FINRA. Its up 352% from 5,000 shares, reported previously.

The stock increased 7.69% or $0.0002 during the last trading session, reaching $0.0028. About 890,721 shares traded or 73.69% up from the average. Cord Blood America, Inc. (OTCMKTS:CBAI) has 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Cord Blood America, Inc. provides private cord blood and cord tissue stem cell storage services to families in the United States, Puerto Rico, Argentina, Uruguay, and Paraguay. The company has market cap of $3.56 million. The firm offers services, including collection of materials, physician and customer support, transportation, and comprehensive testing. It currently has negative earnings. It also procures birth tissue for organizations utilizing the tissue in the transplantation and/or research of therapeutic based products.

More recent Cord Blood America, Inc. (OTCMKTS:CBAI) news were published by: Prnewswire.com which released: “Cord Blood America Announces Equity Investment by Red Oak Partners, LLC for …” on April 10, 2015. Also Bizjournals.com published the news titled: “Cryo-Cell International files suit, suggests takeover of rival firm” on April 03, 2015. Prnewswire.com‘s news article titled: “Cord Blood America, Inc. Announces Divestiture of Biocordcell Argentina, SA” with publication date: October 03, 2014 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.